Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome. 1999

S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
Division of Infectious Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.

Prospective studies were conducted for nosocomial Pseudomonas aeruginosa infections from February 1, 1994, to October 30, 1995. Of 97 P. aeruginosa isolates from 97 patients, 35 were resistant to ceftazidime. Logistic regression revealed previous cephalosporin or piperacillin use as independent risk factors for nosocomial ceftazidime-resistant P. aeruginosa infection. Pulsed-field gel electrophoresis revealed that four nosocomial ceftazidime-resistant P. aeruginosa infections were caused by cross-infection, probably through medical personnel.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females

Related Publications

S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
December 2008, Journal of Korean medical science,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
January 2013, Srpski arhiv za celokupno lekarstvo,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
June 2004, The Journal of hospital infection,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
January 1989, Journal of hygiene, epidemiology, microbiology, and immunology,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
July 2004, The Journal of hospital infection,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
January 2004, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
January 2010, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
November 2011, Epidemiology and infection,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
February 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
S C Lee, and C P Fung, and P Y Liu, and T C Wang, and L C See, and N Lee, and S C Chen, and W B Shieh
January 2018, PloS one,
Copied contents to your clipboard!